Trial Profile
Namenda as Prevention for Post-Operative Delirium.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 05 Jun 2015
Price :
$35
*
At a glance
- Drugs Memantine (Primary)
- Indications Delirium
- Focus Therapeutic Use
- 31 Jul 2009 New trial record